Jason Adair is Senior Vice President, Corporate Development and Strategy at Liquidia Corporation.
As Senior Vice President, Corporate Development & Strategy at Liquidia, Mr. Adair is responsible for pursuing collaboration and licensing opportunities for the company. Prior to joining Liquidia in 2016, Mr. Adair led business development efforts at BioCryst Pharmaceuticals as their Executive Director of Corporate Development. His work included the commercial launch and subsequent partnering of the company’s first FDA approved drug.
He also worked at MedImmune/AstraZeneca in roles of increasing responsibility in business development, marketing and operations. Before entering the pharmaceutical industry, Mr. Adair worked as an analytical chemist for Syngenta and served as an officer in the United States Army.
He received an MBA from the Tuck School of Business at Dartmouth College and a B.S. in Chemistry from Wake Forest University.